Stock listing
Intellia Therapeutics, Inc.
Selected listing: 38I · TRADEGATE · EUR · DE
Intellia Therapeutics, Inc. (Tradegate:38I), Health Technology. Latest release Oct 2, 2026: Intellia Therapeutics Reports Inducement Grants Under Nasdaq…
- Ticker
- Tradegate:38I
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
About Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative gene editing therapies. Intellia is dedicated to advancing its research and development efforts in the field of genetic medicine.
Latest news from Intellia Therapeutics, Inc.
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)
September 8, 2026
Intellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million
September 4, 2026
Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference
September 4, 2026
Events
Research Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. company profile
View the public company page for Intellia Therapeutics, Inc. on 6ix.
Intellia Therapeutics, Inc. news
Read company news and market updates connected to Intellia Therapeutics, Inc..
Intellia Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Intellia Therapeutics, Inc..
Alternate listings
NTLA:NASDAQ
US · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
38I:GETTEX
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
A2AG6H:LSX
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
NTLA:BOATS
US · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
A2AG6H:LS
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
38I:HAM
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
0JBU:LSE
GB · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
38I:FWB
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
38I:SWB
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
38I:BX
CH · CHF
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
38I:DUS
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.
38I:MUN
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is 38I:TRADEGATE.